EC research programme positive for devices industry:
This article was originally published in Clinica
Executive Summary
Eucomed, the European medical device industry association, has welcomed enthusiastically the European Commission's proposal for its next research programme, confident that it promises "fertile conditions" in which the medical devices industry will innovate and thrive. "We are pleased to see that a particular emphasis has been placed on the development and validation of new therapies, diagnostic tools and technologies," director general Maurice Wagner, has commented on the 7th Framework Programme for Research 2007-2013. The industry association has expressed its approval at seeing nanotechnology and emerging technologies as receiving particular attention, using the opportunity to highlight the potential that nanotechnology has in terms of future cancer treatment.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.